Low dose systemic AAV-exendin-4 gene therapy for Prader-Willi syndrome and dietary obesity.

Mol Ther Adv · 2026 · PMC13148920 · PMID 42137604

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Magel2 -null mice showed a trend of Adipoq (encoding adiponectin) downregulation in the eWAT, which was reversed by Rec2-Ex4 treatment.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.